scholarly article | Q13442814 |
P2093 | author name string | A Fournier | |
J G Filep | |||
C Baron | |||
C Zouki | |||
P2860 | cites work | Increased plasma concentrations of endothelin-1 and big endothelin-1 in acute myocardial infarction | Q69371206 |
Effect of endothelin-1 on neutrophil adhesion to endothelial cells and perfused heart | Q70470411 | ||
Subtype selectivity of a novel endothelin antagonist, FR139317, for the two endothelin receptors in transfected Chinese hamster ovary cells | Q70552774 | ||
Blocked ETA receptors prevent ischemia and reperfusion injury in rat lungs | Q71628464 | ||
Time course of coronary vascular endothelial adhesion molecule expression during reperfusion of the ischemic feline myocardium | Q71669842 | ||
Role of endothelin in the pathophysiology of renal ischemia-reperfusion in normal rabbits | Q71690209 | ||
Endothelin-1 causes sequential trapping of platelets and neutrophils in pulmonary microcirculation in rats | Q71738129 | ||
Autocrine effects of endothelin-1 on leukocyte-endothelial interaction: stimulation of endothelin B receptor subtype reduces endothelial adhesiveness via a nitric oxide-dependent mechanism | Q71775719 | ||
Plasma Endothelin Correlates With Antiendothelial Antibodies in Patients With Mixed Connective Tissue Disease | Q71807512 | ||
ICAM-1 expression on cardiac myocytes and aortic endothelial cells via their specific endothelin receptor subtype | Q71859780 | ||
Effects of aspirin on platelet-neutrophil interactions. Role of nitric oxide and endothelin-1 | Q72642263 | ||
Downregulation of endothelin receptors by autocrine production of endothelin-1 | Q72848632 | ||
Glucocorticoid receptor regulates expression of L-selectin and CD11/CD18 on human neutrophils | Q73543011 | ||
Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor | Q28580331 | ||
Contribution of endogenous endothelin to the extension of myocardial infarct size in rats | Q28771364 | ||
Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm | Q29547181 | ||
LIGAND: A versatile computerized approach for characterization of ligand-binding systems | Q29547346 | ||
Leukocyte-endothelial cell recognition: Three (or more) steps to specificity and diversity | Q29617967 | ||
Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788. | Q35315000 | ||
Acute pro‐inflammatory actions of endothelin‐1 in the guinea‐pig lung: involvement of ETA and ETB receptors | Q35871911 | ||
Effects of endothelin-1 on vascular permeability in the conscious rat: interactions with platelet-activating factor | Q35872665 | ||
Endothelial cell-associated platelet-activating factor: a novel mechanism for signaling intercellular adhesion | Q36222548 | ||
Prevention of In vitro neutrophil adhesion to endothelial cells through shedding of L-selectin by C-reactive protein and peptides derived from C-reactive protein | Q37370255 | ||
Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. | Q40576701 | ||
Pharmacology of the endothelium in ischemia-reperfusion and circulatory shock | Q40908234 | ||
Aggregation of human polymorphonuclear leukocytes by endothelin: role of platelet-activating factor | Q41104370 | ||
Human monocyte adhesion is modulated by endothelin B receptor-coupled nitric oxide release. | Q41134562 | ||
Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis | Q41160044 | ||
Role of endothelin-1 in the activation of polymorphonuclear leukocytes. | Q41610462 | ||
Antibodies against human neutrophil LECAM-1 (LAM-1/Leu-8/DREG-56 antigen) and endothelial cell ELAM-1 inhibit a common CD18-independent adhesion pathway in vitro | Q41672543 | ||
Cloning and expression of a cDNA encoding an endothelin receptor | Q41710266 | ||
Heterogeneity of endothelin‐sarafotoxin receptors mediating contraction of pig coronary artery | Q41828520 | ||
Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist | Q42283587 | ||
Phosphoramidon inhibits the generation of endothelin-1 from exogenously applied big endothelin-1 in cultured vascular endothelial cells and smooth muscle cells | Q42474302 | ||
Renal effects and mesangial cell contraction induced by endothelin are mediated by PAF. | Q42476778 | ||
Circulating endothelin in acute ischaemic syndromes | Q42577631 | ||
Increased plasma level of endothelin-1-like immunoreactivity during coronary spasm in patients with coronary spastic angina | Q44720571 | ||
Endothelin induction of adhesion molecule expression on human brain microvascular endothelial cells | Q48265497 | ||
Endothelin stimulates phosphoinositide hydrolysis and PAF synthesis in brain microvessels | Q48882651 | ||
Activated neutrophil by endothelin-1 caused tissue damage in human umbilical cord | Q49225271 | ||
A potent and specific agonist, Suc-[Glu9,Ala11,15]-endothelin-1(8-21), IRL 1620, for the ETB receptor | Q53846586 | ||
Pharmacological actions of WEB 2086, a new specific antagonist of platelet activating factor. | Q53877552 | ||
Autocrine receptors for endothelins in the primary culture of endothelial cells of human umbilical vein | Q67486521 | ||
IFN-gamma regulates the expression of the adhesion molecule ELAM-1 and IL-6 production by human endothelial cells in vitro | Q67670233 | ||
Role of endothelial leukocyte adhesion molecule-1 and platelet-activating factor in neutrophil adherence to IL-1-prestimulated endothelial cells. Endothelial leukocyte adhesion molecule-1-mediated CD18 activation | Q67697151 | ||
Leukocyte adhesion molecule-1 (LAM-1, L-selectin) interacts with an inducible endothelial cell ligand to support leukocyte adhesion | Q67701303 | ||
Endothelin. Key to coronary vasospasm? | Q67779693 | ||
Circulating immunoreactive endothelin in ischemic heart disease | Q68414292 | ||
Endothelin-1 enhances superoxide generation of human neutrophils stimulated by the chemotactic peptide N-formyl-methionyl-leucyl-phenylalanine | Q68490159 | ||
Chemoattractant-regulated mobilization of a novel intracellular compartment in human neutrophils | Q69249421 | ||
Effects of C-reactive protein on human neutrophil granulocytes challenged with N-formyl-methionyl-leucyl-phenylalanine and platelet-activating factor | Q69335713 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | endothelium | Q111140 |
P1104 | number of pages | 11 | |
P304 | page(s) | 969-979 | |
P577 | publication date | 1999-06-01 | |
P1433 | published in | British Journal of Pharmacology | Q919631 |
P1476 | title | Endothelin-1 enhances neutrophil adhesion to human coronary artery endothelial cells: role of ET(A) receptors and platelet-activating factor | |
P478 | volume | 127 |
Q34159332 | 20-Hydroxyeicosatetraenoic acid synthesis is increased in human neutrophils and platelets by angiotensin II and endothelin-1. |
Q50448734 | Amelioration of bleomycin-induced pulmonary fibrosis in a mouse model by a combination therapy of bosentan and imatinib. |
Q44176969 | An endothelin receptor antagonist, SB-217242, inhibits airway hyperresponsiveness in allergic mice |
Q93150619 | Association between circulating big endothelin-1 and noncalcified or mixed coronary atherosclerotic plaques |
Q36364214 | Association of endothelin-1 and matrix metallopeptidase-9 with metabolic syndrome in middle-aged and older adults |
Q36930652 | Bosentan regulates the expression of adhesion molecules on circulating T cells and serum soluble adhesion molecules in systemic sclerosis-associated pulmonary arterial hypertension |
Q46641499 | Bosentan, an endothelin receptor antagonist, reduces leucocyte adhesion and inflammation in a murine model of inflammatory bowel disease |
Q42252132 | Cellular and molecular mechanisms of intestinal fibrosis |
Q57808339 | Design and Rationale for the Endothelin-1 Receptor Antagonism in the Prevention of Microvascular Injury in Patients with non-ST Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention (ENDORA-PCI) Trial |
Q28580085 | ETA and ETB receptor function in pancreatitis-associated microcirculatory failure, inflammation, and parenchymal injury |
Q41865519 | Effect of endothelin-1 receptor antagonists on histological and ultrastructural changes in the pancreas and trypsinogen activation in the early course of caerulein-induced acute pancreatitis in rats |
Q53818426 | Effects of Virgin Olive Oils Differing in Their Bioactive Compound Contents on Metabolic Syndrome and Endothelial Functional Risk Biomarkers in Healthy Adults: A Randomized Double-Blind Controlled Trial. |
Q36705621 | Endothelial injury in the initiation and progression of vascular disorders |
Q34698765 | Endothelin and platelet-activating factor: significance in the pathophysiology of ischemia/reperfusion-induced fetal growth restriction in the rat |
Q43832439 | Endothelin in the mechanism of endothelial injury and neutrophil adhesion in the post-ischemic guinea-pig heart |
Q36619734 | Endothelin-1 and the kidney--beyond BP. |
Q34722259 | Endothelin-1 as a target for therapeutic intervention in prostate cancer |
Q34768934 | Endothelin-1 inhibits apoptosis in prostate cancer |
Q35041995 | Endothelin-1-induced ET(A) receptor-mediated nociception, hyperalgesia and oedema in the mouse hind-paw: modulation by simultaneous ET(B) receptor activation |
Q40183523 | Endothelins mediate neutrophil activation, ProMMP-9 release and endothelial cell detachment. |
Q40417890 | Endothelins modulate inflammatory reaction in zymosan-induced arthritis: participation of LTB4, TNF-alpha, and CXCL-1. |
Q35044172 | Extracellular signal-regulated kinase plays an essential role in endothelin-1-induced homotypic adhesion of human neutrophil granulocytes |
Q37476133 | First insight into the proteome landscape of the porcine short posterior ciliary arteries: Key signalling pathways maintaining physiologic functions |
Q47880572 | Functional autoantibodies targeting G protein-coupled receptors in rheumatic diseases |
Q35815897 | Genome-Wide Association Study of Peripheral Arterial Disease in a Japanese Population |
Q77386364 | Increased endothelin-1 plasma levels in giant cell arteritis: a report on four patients |
Q47968999 | Infusion of exogenous platelet-activating factor produces intrauterine growth restriction in the rat. |
Q41473918 | Lipoxin A(4) attenuates zymosan-induced arthritis by modulating endothelin-1 and its effects |
Q24797480 | Methods for analysis of matrix metalloproteinase regulation of neutrophil-endothelial cell adhesion |
Q36746486 | Pediatric respiratory and systemic effects of chronic air pollution exposure: nose, lung, heart, and brain pathology |
Q51364946 | Potential role for ET-2 acting through ETA receptors in experimental colitis in mice. |
Q57570922 | Pulmonary Fibrosis and Chronic Lung Inflammation in ET-1 Transgenic Mice |
Q43262736 | Role for endogenous endothelin in the regulation of plasma volume and albumin escape during endotoxin shock in conscious rats |
Q28216230 | Role of endothelin in cardiovascular disease |
Q40261478 | The endothelin B receptor plays a crucial role in the adhesion of neutrophils to the endothelium in sickle cell disease |
Q37683295 | The endothelin-integrin axis is involved in macrophage-induced breast cancer cell chemotactic interactions with endothelial cells |
Q36067020 | The role of endothelin-1 in myocarditis and inflammatory cardiomyopathy: old lessons and new insights. |
Q33733189 | The significance of endothelin in platelet-activating factor-induced fetal growth restriction |
Q47340635 | Transgenic mice over-expressing endothelin-1 in testis transactivated by a Cre/loxP system showed decreased testicular capillary blood flow |
Q36024864 | Trypanosoma cruzi invades host cells through the activation of endothelin and bradykinin receptors: a converging pathway leading to chagasic vasculopathy. |
Q53421304 | Vascular endothelial cell-derived endothelin-1 mediates vascular inflammation and neointima formation following blood flow cessation. |
Q36130959 | Vasculitis: mechanisms involved and clinical manifestations |
Search more.